Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An anal squamous cell carcinoma characterized by the presence of malignant cells with hyperchromatic nuclei and peripheral nuclear palisading.
Biomarker and diagnostic research for anus basaloid carcinoma has been reported in the published literature.
3 clinical trials registered. Interventions under study include drug therapy, other interventions, procedural interventions, and biologic therapy. Pipeline includes 2 PHASE3, 1 PHASE2. Research is primarily sponsored by academic and government institutions.
4 publications have been identified in PubMed for anus basaloid carcinoma. Research spans Basic Science / Preclinical (50%), Diagnostic / Biomarker (25%), and Case Report / Case Series (25%).
Zhu X (2025). [PMID: 40180056](https://pubmed.ncbi.nlm.nih.gov/40180056/). *Human pathology*. [Basic Science / Preclinical]
Wong NA (2025). [PMID: 40539551](https://pubmed.ncbi.nlm.nih.gov/40539551/). *Histopathology*. [Basic Science / Preclinical]
Suzuki Y (2024). [PMID: 38346737](https://pubmed.ncbi.nlm.nih.gov/38346737/). *Internal medicine (Tokyo, Japan)*. [Diagnostic / Biomarker]
Fuentes-Calvo KJ (2024). [PMID: 39211371](https://pubmed.ncbi.nlm.nih.gov/39211371/). *Journal of surgical case reports*. [Case Report / Case Series]
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 6:53 PM UTC